Release Technology

Butyrate has a very pungent odor which makes the oral intake unpleasant, moreover, once ingested, it is rapidly absorbed in the upper part of the gastrointestinal tract, an event that considerably reduces its positive effects in the colon. These characteristics affect the clinical utility of butyrate, administered as such.
To overcome these limitations, Dibuzin^® tablets are formulated in a double-layer pharmaceutical form to promote a protracted release of butyrate throughout intestinal transit.